Cargando…
A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells
The cytokine IL-17A is associated with the progression of various cancers, but little is known about the molecular cross-talk between IL-17A and other tumor-promoting factors. Previous studies have shown that the IL-17A-mediated invasion of breast cancer cells can be inhibited by selective antagonis...
Autores principales: | Koslawsky, Dana, Zaretsky, Marianna, Alcalay, Ron, Mazor, Ohad, Aharoni, Amir, Papo, Niv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033355/ https://www.ncbi.nlm.nih.gov/pubmed/29983876 http://dx.doi.org/10.18632/oncotarget.25526 |
Ejemplares similares
-
Targeting the Tie2–α(v)β(3) integrin axis with bi-specific reagents for the inhibition of angiogenesis
por: Shlamkovich, Tomer, et al.
Publicado: (2018) -
Inorganic sulfur reduces the motility and invasion of MDA-MB-231 human breast cancer cells
por: Kim, Jin Joo, et al.
Publicado: (2011) -
PAX6 Promoter Methylation Correlates with MDA-MB-231 Cell Migration, and Expression of MMP2 and MMP9
por: Urrutia, Guillermo, et al.
Publicado: (2018) -
Fra-1 regulation of Matrix Metallopeptidase-1 (MMP-1) in metastatic variants of MDA-MB-231 breast cancer cells
por: Henckels, Eric, et al.
Publicado: (2013) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010)